Contribución al desarrollo de una formulación líquida de administración oral para un extracto de hojas de Passiflora quadrangularis L aplicando los conceptos del enfoque de calidad basada en el diseño (QbD)
| dc.contributor.advisor | Baena Aristizábal, Yolima | spa |
| dc.contributor.author | Porras Gaviria, David Orlando | spa |
| dc.contributor.researchgroup | GRUPO DE INVESTIGACIÓN EN TECNOLOGÍA DE PRODUCTOS NATURALES - TECPRONA | spa |
| dc.date.accessioned | 2020-03-09T13:09:20Z | spa |
| dc.date.available | 2020-03-09T13:09:20Z | spa |
| dc.date.issued | 2019-07-20 | spa |
| dc.description.abstract | Objectives previously defined are the starting point of Quality by design (QbD) to ensure the quality, safety and efficacy of the product. This research was focused on the exemplifies of some QbD principles in the development of a liquid formulation from a hydroalcoholic extract of leaves of Passiflora quadrangularis, specifically those that affect the formulation proposal and the manufacturing process. In the first stage Target Product Profile, Quality Target Product Profile and Critical Quality Attributes were determined through interviews to health professionals and reviewing the scientific literature. This information guided the other process stages. In the preformulation tests, the effect of temperature, light, ethanol concentration and the effect of a polyol on response variables such as pH, color, amount of precipitate and quantification of markers was evaluated. Light was the only variable having a statistically significant effect on stability of the extract. The antimicrobial efficacy test demonstrates the self-preserved capacity of P. quadrangularis. This information will propose a prototype formulation and the corresponding manufacturing process, our risk analysis (RAM Matrix and FMEA matrix) will facilitate the design of proposals regarding control strategies. | spa |
| dc.description.abstract | El enfoque de calidad basado en el diseño (QbD) tiene como punto de partida unos objetivos previamente definidos que permiten asegurar la calidad, seguridad y eficacia del producto. El presente trabajo de investigación ejemplifica la implementación de algunos principios de QbD en el desarrollo de una formulación líquida a partir de un extracto hidroalcohólico de hojas de Passiflora quadrangularis, específicamente aquellos que aplican hasta la propuesta de la formulación y del proceso de fabricación. En su primera fase se determinó el perfil del producto, el perfil de calidad del producto y los atributos críticos de calidad, mediante entrevista a profesionales de la salud y revisión de la literatura científica. Esta información orientó las demás etapas del trabajo. Así, en los ensayos de preformulación se evaluó el efecto de la temperatura, la luz, la concentración de etanol y el tipo de poliol sobre variables respuesta como pH, color, cantidad de precipitado y cuantificación de marcadores. La luz fue la única variable que tuvo un efecto estadísticamente significativo sobre la estabilidad del extracto. La prueba de eficacia antimicrobiana evidenció la capacidad de autopreservación del extracto de P. quadrangularis. Esta información permitió proponer un prototipo de formulación y el proceso de fabricación correspondiente, cuyo análisis del riesgo (matriz RAM y matriz FMEA) facilitó el diseño de propuestas respecto a las estrategias de control. | spa |
| dc.description.additional | Magíster en Ciencias Farmacéuticas. Línea de Investigación: Diseño y desarrollo de productos fitofarmacéuticos | spa |
| dc.description.degreelevel | Maestría | spa |
| dc.description.project | Red Nacional para la Bioprospección de Frutas Tropicales RIFRUTBIO | spa |
| dc.description.sponsorship | COLCIENCIAS | spa |
| dc.format.extent | 135 | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.uri | https://repositorio.unal.edu.co/handle/unal/75969 | |
| dc.language.iso | spa | spa |
| dc.publisher.branch | Universidad Nacional de Colombia - Sede Bogotá | spa |
| dc.publisher.department | Departamento de Farmacia | spa |
| dc.relation.references | Atanasov AG, Waltenberger BA, Pferschy EM, Linder TD, Wawrosch CA, Uhrin PS, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33(8):1582–1614. | spa |
| dc.relation.references | Rather MA, Bhat BA, Qurishi MA. Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down?. Phytomedicine. 2013;21(1):1–14. | spa |
| dc.relation.references | Bruno D, Wolfender JL, Dias DA. The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev. 2014;14(2):299–315. | spa |
| dc.relation.references | Cragg GM, Newman DJ. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta. 2013;1830(6):3670–3695. | spa |
| dc.relation.references | Rocha H, Cuadro J, Mora C. Aplicación de la calidad basada en el diseño (QbD) en la reformulación de tabletas masticables. Rev. colomb. cienc. quim. farm. 2013;42(2):190–214. | spa |
| dc.relation.references | ISPE. Concepts and Principles SPE Guide Series: PQLI® from Concept to Continual Improvement Product Realization using Quality by Design (QbD). Part 1 Product Realization using Quality by Design (QbD): Concepts and Principles. 2011: 11–39. | spa |
| dc.relation.references | Janssen W. The Story of the Laws Behind the Label. 1th. ed. United States of America: FDA; 1962. | spa |
| dc.relation.references | Ponce LF, Rodríguez A. Buenas Prácticas de Manufactura Vigentes y su relación con la Garantia De Calidad. Rev. colomb. cienc. quim. farm. 1992;20: 63–68. | spa |
| dc.relation.references | Charoo NA, Shamsher AAA, Zidan AS, Rahman Z. Quality by design approach for formulation development: A case study of dispersible tablets. Int. J. Pharm. 2012;423(2):167–178. | spa |
| dc.relation.references | World Health Organization. Expert Committee on Specifications for Pharmaceutical Preparations. WHO Technical Report Series. Geneve. 1992;24-35. | spa |
| dc.relation.references | Mora CE. “Nuevos enfoques” de las Buenas Prácticas de Manufactura. Rev. colomb. cienc. quim. farm. 2009;38(1):42–58. | spa |
| dc.relation.references | García OF, Vallejo BM, Mora CE. La calidad desde el diseño: principios y oportunidades para la industria farmacéutica. Estud.Gerenc. 2015;31(134):68–78. | spa |
| dc.relation.references | Welch KA, Fung CA, Schmidt SS. Risk/Science-based approach to validation: A win-win-win for patients, regulators, and industry. Pharm. Sci. Technol. 2004;58(45):15–23. | spa |
| dc.relation.references | Zhang L, Mao S. Applications of quality by design (QbD) and its tools in drug delivery. Asian J. Pharm. 2016;11(1):144–155. | spa |
| dc.relation.references | Patel GM, Shelat PK, Lalwani AN. QbD based development of proliposome of lopinavir for improved oral bioavailability. Eur. J. Pharm. Sci. 2016;9(4):225-248 | spa |
| dc.relation.references | Mhatre R, Rathore A. Quality by design: an overview of the basic concepts. Quality by Design for Biopharmaceuticals. John Wiley & Sons. 2009. | spa |
| dc.relation.references | Yan B, Li Y, Guo Z, Qu H. Quality by design for herbal drugs: A feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes. Phytochem. Anal. 2014;25(1):59–65. | spa |
| dc.relation.references | Uhlenbrock L, Sixt M, Tegtmeier M, Schulz H, Hagels H, Ditz R, et al. Natural products extraction of the future sustainable manufacturing solutions for societal needs. Processes. 2018;6(10):2-28. | spa |
| dc.relation.references | Kroll U, Cordes C. Pharmaceutical prerequisites for a multi-target therapy. Phytomedicine. 2006;13(2):12–19. | spa |
| dc.relation.references | Yousef SA, Mohammed YH, Namjoshi S, Grice JE, Benson HAE, Sakran W, et al. Mechanistic evaluation of enhanced curcumin delivery through human skin in vitro from optimised nanoemulsion formulations fabricated with different penetration enhancers. Pharmaceutics. 2019;11(12):2-20. | spa |
| dc.relation.references | Carriço C, Pinto P, Graça A, Gonçalves LM, Ribeiro HM, Marto J. Design and characterization of a new quercus suber based pickering emulsion for topical application. Pharmaceutics. 2019;11(3):1–16. | spa |
| dc.relation.references | Thakur D, Jain A, Ghoshal G, Shivhare US, Katare OP. RP-HPLC method development using analytical QbD approach for estimation of cyanidin-3-O-glucoside in natural biopolymer based microcapsules and tablet dosage form. J Pharm. Investig. 2017;47(5):413–427. | spa |
| dc.relation.references | Sharma R, Kamboj S, Khurana R, Singh G, Rana V. Physicochemical and functional performance of pectin extracted by QbD approach from Tamarindus indica L. pulp. Carbohydr. Polym. 2015;134:364–374. | spa |
| dc.relation.references | Organización Mundial para la Salud. Salud mental: Fortalecer nuestra respuesta. Colombia. 2016. | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. Guía de manejo para trastornos de ansiedad. Colombia. 2014;1–47. | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. Encuesta Nacional de Salud Mental 2015. Colombia. Tomo I. 2015. | spa |
| dc.relation.references | López F, Álamo C, García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs. J. Anxiety Disord. 2011;25(4):554–562. | spa |
| dc.relation.references | López C, Estrada E. Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. J. Ethnopharmacol. 2016;186:377–391. | spa |
| dc.relation.references | Ajao MY, Akindele AJ. Anxiolytic and sedative properties of hydroethanolic extract of Telfairia occidentalis leaves in mice. Rev. bras. farmacogn. 2013;23(2):301–309. | spa |
| dc.relation.references | Ketcha GJM, Djiogue S, Gamo FZ, Ngitedem SG, Njamen D. Anxiolytic and sedative activities of aqueous leaf extract of Dichrocephala integrifolia (Asteraceae) in mice. J. Ethnopharmacol. 2015;176:494–508. | spa |
| dc.relation.references | Ávila G, González ME, Carballo AI, Aguilar B, García S, Giles DE, et al. Anxiolytic-like effects and toxicological studies of Brickellia cavanillesii (Cass.) A. Gray in experimental mice models. J. Ethnopharmacol. 2016;192:90–98. | spa |
| dc.relation.references | Khan IN, Sarker MMI, Ajrin M. Sedative and anxiolytic effects of ethanolic extract of Calotropis gigantea (Asclepiadaceae) leaves. Asian Pac J Trop Biomed. 2014;4:400-404. | spa |
| dc.relation.references | Kebebew Z, Shibeshi W. Evaluation of anxiolytic and sedative effects of 80% ethanolic Carica papaya L. (Caricaceae) pulp extract in mice. J. Ethnopharmacol. 2013;150(2):665–671. | spa |
| dc.relation.references | Nwosu MO. Herbs for mental disorders. Fitoterapia. 1999;70:58–63. | spa |
| dc.relation.references | Sollozo I, Estrada E, Carro M, López C. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa. J. Ethnopharmacol. 2015;162:278–286. | spa |
| dc.relation.references | Sandoval MD. Huila es potencia mundial en Passifloras. El Espectador.2013. | spa |
| dc.relation.references | Ministerio de Agricultura y Desarrollo Rural. Sistema de información de gestión y desempeño de organizaciones de cadenas. Retrieved. 2015. | spa |
| dc.relation.references | Barrios L. "Estudios de la diversidad de Passifloreacea en los departamentos de Caldas, Choco,Nariño, Quindio, Risaralda y Valle del Cauca (Colombia), Apoyados en los análisis ecogeográficos, palinológicos y citogenéticos" Tesis de Maestría. Universidad Nacional de Colombia; 2005: 38-59. | spa |
| dc.relation.references | Dhawan K, Dhawan S, Sharma A. Passiflora: A review update. J. Ethnopharmacol. 2004;94(1):1–23. | spa |
| dc.relation.references | Medina HI. "Aporte al diseño de un sistema microparticulado para un extracto de Passiflora quadrangularis Linn" Tesis de Maestría. Universidad Nacional de Colombia; 2014:30-75. | spa |
| dc.relation.references | Hanada S. Pharmacological Trials of Crude Extract of Passiflora alata. Planta Medica. New York. Georg Thieme Verlag Stuttgart. 1984;303–316. | spa |
| dc.relation.references | Hickey M, King C. 100 Families of Flowering Plants. United Kingdom. Cambridge Univ Press. 1988;130–153. | spa |
| dc.relation.references | Felter HW, Lloyd J. King’s American Dispensatory. The plants. United State. Eighteenth edition 1898;89-112 | spa |
| dc.relation.references | Chopra RN, Nayar SL, Chopra I. Glossary of Indian Medicinal Plants. India. 1956;186–187. | spa |
| dc.relation.references | Seaforth CE, Adams CD, Sylvester Y. A Guide for the Medicinal Plants of Trinidad & Tobago. Commonw Secreteriate, Marlbrgh House, Pall Mall. 1983;95-102. | spa |
| dc.relation.references | Bergner P. Passionflower. “Aust. J. Medical Herbal. 7;13–24. | spa |
| dc.relation.references | Domínguez LF. "Evaluación cualitativa de la solubilidad de flavonoides presentes en un extracto de hojas de Passiflora quadrangularis" Tesis de Grado. Universidad Nacional de Colombia; 2016:20-45. | spa |
| dc.relation.references | Osorio C, Duque C, Fujimoto Y. Oxygenated monoterpenoids from badea (Passiflora quadrangularis) fruit pulp. Phytochemistry. 2000;53(1):97–101. | spa |
| dc.relation.references | Gazola AC. Flavonoid constituents of Passiflora quadrangularis Linneaus leaves aqueous extract and the in vivo sedative activity through GABAergic pathway. J Ethnopharmacol. 2015;100–125. | spa |
| dc.relation.references | Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem. Pharmacol. 2000;59(11):1387–1394. | spa |
| dc.relation.references | Gazola AC, Costa GM, Castellanos L, Ramos F a., Reginatto FH, Lima TCM De, et al. Involvement of GABAergic pathway in the sedative activity of apigenin, the main flavonoid from Passiflora quadrangularis pericarp. Rev. bras. farmacogn. 2015;25(2):158–163. | spa |
| dc.relation.references | Porras D. "Estudio para la evaluación de la compatibilidad entre un extracto de Passiflora quadrangularis y algunos excipientes" Tesis de Grado. Universidad Nacional De Colombia 2016:2–16. | spa |
| dc.relation.references | Echeverry S. "Aporte a la estandarización del proceso de obtención de un extracto de hojas de Passiflora quadrangularis" Tesis de Maestría. Universidad Nacional de Colombia; 2017:16-58. | spa |
| dc.relation.references | Herrera J, Cardenas P. "Contribución al estudio de la estabilidad de 6-metilcumarina libre y microencapsulada" Tesis de grado. Universidad Nacional de Colombia; 2016:10-19. | spa |
| dc.relation.references | Convención farmacopeica de los Estados Unidos. Prueba de eficacia antimicrobiana. Farmacopea de los Estados Unidos de América 38. 2015:1034-1038. | spa |
| dc.relation.references | Maguire J, Peng D, Ostrove S, Brindle A, Davy S, Tiffany D, et al. Risk Analysis and Mitigation Matrix (RAMM) – A Risk Tool for Quality Management. FDA 2nd Conf. 2011;32(1):1–19. | spa |
| dc.relation.references | Carbone TA, Tippett DD. Project risk management using the project risk FMEA. Eng Manag J. 2004;16(4):28–35. | spa |
| dc.relation.references | Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development : A quality by design approach. Int J Pharm Investig. 2016;24(9):129-140. | spa |
| dc.relation.references | FDA. Target Product Profile a Strategic Development Guidance for Industry and Review Staff Target Product Profile. Guidance for Industry and Review Staff. FDA Guidance. 2007;13.-14. | spa |
| dc.relation.references | Gutiérrez SL, Chilpa RR, Jahms HB. Medicinal plants for the treatment of “nervios”, anxiety, and depression in Mexican Traditional Medicine. Rev. bras. farmacogn. 2014;24(5):591–608. | spa |
| dc.relation.references | Saffari M, Ebrahimi A, Langrish T. A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol. Eur J Pharm Sci. 2016;83:52–61. | spa |
| dc.relation.references | Melo JG, Santos AG, De Amorim EL. Medicinal plants used as antitumor agents in Brazil: An ethnobotanical approach. Evid-Based Compl Alt. 2011;5:2-8. | spa |
| dc.relation.references | Brantley S, Argikar A, Lin. Y, Nagar S, Paine M. Herb-drug interactions: Challenges and opportunities for improved predictions. Drug Metab Dispos. 2014;42(3):301–317. | spa |
| dc.relation.references | Barnes PM, Powell-griner E, Mcfann K, Nahin RL. Complementary and Alternative Medicine Use Among Adults: United States 2002. Res. Integr. Med. 2004;5:54-63 | spa |
| dc.relation.references | Khan IA. Issues related to botanicals. Life Sci. 2006;78(18):2033–2038. | spa |
| dc.relation.references | Costa D, Ulbricht C, Chao W, Weissner W, Rusie-Seamon E, Woods J. Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration. Curr. Drug Metab. 2008;9(10):1063–1120. | spa |
| dc.relation.references | Villas GR, Stefanello AP, Feitosa BC, Lima CA, Arce E, Oesterreich SA. The ethanolic extract obtained from Campomanesia pubescens (D.C.) O.BERG fruits exerts anxiolytic and antidepressant effects on chronic mild stress model and on anxiety models in Wistar rats: Behavioral evidences. Nutr Neurosci. 2018;7(2):1–11. | spa |
| dc.relation.references | Akhondzadeh S, Naghavi HV. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26:363–367. | spa |
| dc.relation.references | Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: A double-blind, placebo-controlled study. Anesth Analg. 2008;106(6):1728–1732. | spa |
| dc.relation.references | Schulz H, Jobert M, Hübner WD. The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam. Phytomedicine. 1998;5(6):449–458. | spa |
| dc.relation.references | Ngan A, Conduit R. A Double-blind , Placebo‐controlled Investigation of the Effects of Passiflora incarnata ( Passionflower) Herbal Tea on Subjective Sleep Quality. Phytother. Res. 2011;11:1153–1159. | spa |
| dc.relation.references | Bourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: Controlled study versus placebo. Fundam Clin Pharmacol. 1997;11(2):127–132. | spa |
| dc.relation.references | González L. "Passiflora en el tratamiento de la ansiedad y el insomnio" Tesis Doctorado. Universidad Complutense; 2017;25-115. | spa |
| dc.relation.references | INVIMA. Sistema de Tramites en Línea - Consultas Públicas [Internet]. [cited 2019 Jun 17]. | spa |
| dc.relation.references | Méndez G, Fuentes VR, Soler BA, Villanueva G, Lemes Hernández GM, Rodríguez A. Variación de índices farmacognósticos en Passiflora incarnata L. con la época y hora de cosecha de la droga. Rev Cuba Plantas Med. 2001;6(3):98–104. | spa |
| dc.relation.references | Bent S. Herbal medicine in the United States: Review of efficacy, safety, and regulation - Grand Rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23(6):854–859. | spa |
| dc.relation.references | Khadra I, Zhou Z, Dunn C, Wilson CG, Halbert G. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs. Eur J Pharm Sci. 2015;67:65–75. | spa |
| dc.relation.references | Ministerio Salud y Protección Social. Decreto 1156 de 2018. Colombia. 06 de Julio de 2018; 2018:1–25. | spa |
| dc.relation.references | Presidencia de la República de Colombia. Decreto 549 de 2001. Colombia. 29 de marzo de 2001; 2001:1–24. | spa |
| dc.relation.references | Modesti G. "Estudo químico de espécies brasileiras e Colombianas do Genero Passiflora" Tesis Doctorado. Universidad Federal de Santa Catarina; 2013:45-85. | spa |
| dc.relation.references | Echeverry SM, Medina HI, Costa GM, Aragón DM. Optimization of flavonoid extraction from Passiflora quadrangularis leaves with sedative activity and evaluation of its stability under stress conditions. Rev. bras. farmacogn. 2018;28(5):610–617. | spa |
| dc.relation.references | Rowe R. Sorbitol. Handbook of Pharmaceutical Excipients. Press P. Sixth Edit. 2009:679–681. | spa |
| dc.relation.references | Rowe R. Glycerin. Handbook of Pharmaceutical Excipients. Press P. Sixth Edit. 2009:284–286. | spa |
| dc.relation.references | Markham KR. Techniques of Flavonoids Identification. Academic P. Londres; 1982. | spa |
| dc.relation.references | Chopin J, Bouillant M, Bess E. C-Glycosyl flavonoids. The Flavonoids Advances in Research. 1982:449–498. | spa |
| dc.relation.references | Patras A. Stability and color evaluation of red cabbage waste hydroethanolic extract in presence of different food additives or ingredients. Food Chem. 2019;275:539–548. | spa |
| dc.relation.references | Jiang T, Mao Y, Sui L, Yang N, Li S, Zhu Z, et al. Degradation of anthocyanins and polymeric color formation during heat treatment of purple sweet potato extract at different pH. Food Chem. 2019;274:460–70. | spa |
| dc.relation.references | Loutit TS, Keigwin LD. Heat Stability of Strawberry Anthocyanins in Model Solutions Containing Natural Copigments Extracted from Rose (Rosa damascena Mill.) Petals. Nature. 1982;300(5):163–166. | spa |
| dc.relation.references | Ortmann CF. "Avaliação da estabilidade de extratos, frações e flavonoides C-glicosídeos presentes em Cecropia glaziovii" Tesis de Maestría. Universidad Federal de Santa Catarina; 2013:45-56. | spa |
| dc.relation.references | Castañeda A, Pacheco MDL, Páez ME, Rodríguez JA, Galán CA. Chemical studies of anthocyanins: A review. Food Chem. 2009;113(4):859–871. | spa |
| dc.relation.references | Loh ZH, Samanta AK, Sia Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J. Pharm. 2014;10(4):255–274. | spa |
| dc.relation.references | Chen X, Fadda HM, Aburub A, Mishra D, Pinal R. Cosolvency approach for assessing the solubility of drugs in poly(vinylpyrrolidone). Int J Pharm. 2015;494(1):346–356. | spa |
| dc.relation.references | Munin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics. 2011;3:793–829. | spa |
| dc.relation.references | Degani L, Gulmini M, Piccablotto G, Iacomussi P, Gastaldi D, Dal Bello F, et al. Stability of natural dyes under light emitting diode lamps. J Cult Herit. 2017;26:12–21. | spa |
| dc.relation.references | Rice-evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res. 1995;22(4):375–83. | spa |
| dc.relation.references | Majer P, Neugart S, Krumbein A, Schreiner M, Hideg É. Singlet oxygen scavenging by leaf flavonoids contributes to sunlight acclimation in Tilia platyphyllos. Environ Exp Bot. 2014;100:1–9. | spa |
| dc.relation.references | Min DB, Boff JM. Chemistry and reaction of singlet oxygen in foods. Compr Rev Food. 2002;1(2):58–72. | spa |
| dc.relation.references | Hajimohammadi M, Nosrati P. Scavenging effect of pasipay (Passiflora incarnata L.) on singlet oxygen generation and fatty acid photooxygenation. Food Sci Nutr. 2018;6(6):1670–1675. | spa |
| dc.relation.references | Osorio C, Duque C, Fujimoto Y. El aroma de la badea (Passiflora quadrangularis): Composición y generación de compuestos volatiles a partir de glicósidos, fosfatos y monoterpenos oxigenados.Badea. 2005:107–131. | spa |
| dc.relation.references | Orsini F, Pellizzoni F, Ricca G, Verotta L. Triterpene glycosides related to quadranguloside from Passiflora quadrangularis. Phytochemistry. 1987;26(4):1101–1105. | spa |
| dc.relation.references | Machado H, Nagem T, Peters VM, Fonseca CS, Oliveira TT de. Flavonoids and potential therapeutic. Arch. Biochem. Biophys. 2008;27(1):33–39. | spa |
| dc.relation.references | Siebra AL, Oliveira LR, Martins AOBPB, Siebra DC, Lemos ICS, et al. Potentiation of antibiotic activity by Passiflora cincinnata Mast. front of strains Staphylococcus aureus and Escherichia coli. Saudi J Biol Sci. 2018;25(1):37–43. | spa |
| dc.relation.references | Munro M, Albertson G, Perry N, Blunt J, Walker J, Cole A. 4-Hydroxy-2-cyclopentenone: An Anti-Pseudomonas and Cytotoxic Component from Passiflora tetrandra. Planta Med. 2007;57(2):129–31. | spa |
| dc.relation.references | Dzotam JK, Touani FK, Kuete V. Antibacterial and antibiotic-modifying activities of three food plants (Xanthosoma mafaffa Lam., Moringa oleifera (L.) Schott and Passiflora edulis Sims) against multidrug-resistant (MDR) Gram-negative bacteria. BMC Complement Altern Med. 2016;16(1):1–8. | spa |
| dc.relation.references | Pelegrini PB, Noronha EF, Muniz MAR, Vasconcelos IM, Chiarello MD, Oliveira JTA, et al. An antifungal peptide from passion fruit (Passiflora edulis) seeds with similarities to 2S albumin proteins. Biochim Biophys Acta. 2006;1764(6):1141–1146. | spa |
| dc.relation.references | Agizzio AP, Carvalho AO, Ribeiro S de FF, Machado OLT, Alves EW, Okorokov LA, et al. A 2S albumin-homologous protein from passion fruit seeds inhibits the fungal growth and acidification of the medium by Fusarium oxysporum. Arch Biochem Biophys. 2003;416(2):188–195. | spa |
| dc.relation.references | Carvalho O, Anto M, Da M, Ribeiro SFF, Gomes VM. The antifungal properties of a 2S albumin-homologous protein from passion fruit seeds involve plasma membrane permeabilization and ultrastructural alterations in yeast cells. Plant Sci. 2006;171:515–522. | spa |
| dc.rights | Derechos reservados - Universidad Nacional de Colombia | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.license | Atribución-NoComercial 4.0 Internacional | spa |
| dc.rights.spa | Acceso abierto | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | spa |
| dc.subject.ddc | Ciencias naturales y matemáticas | spa |
| dc.subject.ddc | Química y ciencias afines | spa |
| dc.subject.ddc | Plantas | spa |
| dc.subject.ddc | Medicina y salud | spa |
| dc.subject.proposal | Quality by design | eng |
| dc.subject.proposal | Calidad basada en el diseño | spa |
| dc.subject.proposal | Passiflora quadrangularis | eng |
| dc.subject.proposal | Passiflora quadrangularis | spa |
| dc.subject.proposal | Formulación | spa |
| dc.subject.proposal | Risk management | eng |
| dc.subject.proposal | Gestión del riesgo | spa |
| dc.subject.proposal | Formulation | eng |
| dc.subject.proposal | Herbal product | eng |
| dc.subject.proposal | Extracto natural | spa |
| dc.title | Contribución al desarrollo de una formulación líquida de administración oral para un extracto de hojas de Passiflora quadrangularis L aplicando los conceptos del enfoque de calidad basada en el diseño (QbD) | spa |
| dc.type | Trabajo de grado - Maestría | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_bdcc | spa |
| dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/masterThesis | spa |
| dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
| oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |

